These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23060003)

  • 21. Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice.
    Kelavkar UP; Glasgow W; Olson SJ; Foster BA; Shappell SB
    Neoplasia; 2004; 6(6):821-30. PubMed ID: 15720809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of αVβ3 and αVβ6 integrins in prostate cancer progression.
    Quaglia F; Krishn SR; Wang Y; Goodrich DW; McCue P; Kossenkov AV; Mandigo AC; Knudsen KE; Weinreb PH; Corey E; Kelly WK; Languino LR
    PLoS One; 2021; 16(1):e0244985. PubMed ID: 33481853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of Insulinoma-Associated Protein 1 (INSM1) and Orthopedia Homeobox (OTP) in Tumors with Neuroendocrine Differentiation at Rare Sites.
    Roy M; Buehler DG; Zhang R; Schwalbe ML; Baus RM; Salamat MS; Lloyd RV; Rosenbaum JN
    Endocr Pathol; 2019 Mar; 30(1):35-42. PubMed ID: 30523500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An investigation of the effects of late-onset dietary restriction on prostate cancer development in the TRAMP mouse.
    Suttie AW; Dinse GE; Nyska A; Moser GJ; Goldsworthy TL; Maronpot RR
    Toxicol Pathol; 2005; 33(3):386-97. PubMed ID: 15805078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The steroid receptor coactivator-3 is required for developing neuroendocrine tumor in the mouse prostate.
    Tien JC; Liao L; Liu Y; Liu Z; Lee DK; Wang F; Xu J
    Int J Biol Sci; 2014; 10(10):1116-27. PubMed ID: 25332686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FOXA2 drives lineage plasticity and KIT pathway activation in neuroendocrine prostate cancer.
    Han M; Li F; Zhang Y; Dai P; He J; Li Y; Zhu Y; Zheng J; Huang H; Bai F; Gao D
    Cancer Cell; 2022 Nov; 40(11):1306-1323.e8. PubMed ID: 36332622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interspecies comparison of prostate cancer gene-expression profiles reveals genes associated with aggressive tumors.
    Kela I; Harmelin A; Waks T; Orr-Urtreger A; Domany E; Eshhar Z
    Prostate; 2009 Jul; 69(10):1034-44. PubMed ID: 19343735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Forkhead box A2 transcription factor is expressed in all types of neuroendocrine lung tumors.
    Khoor A; Stahlman MT; Johnson JM; Olson SJ; Whitsett JA
    Hum Pathol; 2004 May; 35(5):560-4. PubMed ID: 15138929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer.
    Gururajan M; Cavassani KA; Sievert M; Duan P; Lichterman J; Huang JM; Smith B; You S; Nandana S; Chu GC; Mink S; Josson S; Liu C; Morello M; Jones LW; Kim J; Freeman MR; Bhowmick N; Zhau HE; Chung LW; Posadas EM
    Oncotarget; 2015 Dec; 6(42):44072-83. PubMed ID: 26624980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Programmed Death Ligand 1 (PD-L1) Status and Tumor-Infiltrating Lymphocytes in Hot Spots of Primary and Liver Metastases in Prostate Cancer With Neuroendocrine Differentiation.
    von Hardenberg J; Hartmann S; Nitschke K; Worst TS; Ting S; Reis H; Nuhn P; Weis CA; Erben P
    Clin Genitourin Cancer; 2019 Apr; 17(2):145-153.e5. PubMed ID: 30709785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neuroendocrine differentiation in prostate cancer. An unrecognized and therapy-resistant phenotype].
    Bonkhoff H; Fixemer T
    Urologe A; 2004 Jul; 43(7):836-42. PubMed ID: 15048555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma.
    Alshalalfa M; Liu Y; Wyatt AW; Gibb EA; Tsai HK; Erho N; Lehrer J; Takhar M; Ramnarine VR; Collins CC; Den RB; Schaeffer EM; Davicioni E; Lotan TL; Bismar TA
    Int J Cancer; 2019 Dec; 145(12):3453-3461. PubMed ID: 31125117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes.
    Peek EM; Song W; Zhang H; Huang J; Chin AI
    Prostate; 2015 Apr; 75(5):463-73. PubMed ID: 25597486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential requirement for Src family tyrosine kinases in the initiation, progression, and metastasis of prostate cancer.
    Gelman IH; Peresie J; Eng KH; Foster BA
    Mol Cancer Res; 2014 Oct; 12(10):1470-9. PubMed ID: 25053806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A null-mutation in the Znt7 gene accelerates prostate tumor formation in a transgenic adenocarcinoma mouse prostate model.
    Tepaamorndech S; Huang L; Kirschke CP
    Cancer Lett; 2011 Sep; 308(1):33-42. PubMed ID: 21621325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells.
    Iwata T; Schultz D; Hicks J; Hubbard GK; Mutton LN; Lotan TL; Bethel C; Lotz MT; Yegnasubramanian S; Nelson WG; Dang CV; Xu M; Anele U; Koh CM; Bieberich CJ; De Marzo AM
    PLoS One; 2010 Feb; 5(2):e9427. PubMed ID: 20195545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EGFR-upregulated LIFR promotes SUCLG2-dependent castration resistance and neuroendocrine differentiation of prostate cancer.
    Lin SR; Wen YC; Yeh HL; Jiang KC; Chen WH; Mokgautsi N; Huang J; Chen WY; Liu YN
    Oncogene; 2020 Oct; 39(44):6757-6775. PubMed ID: 32963351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic profiling of transgenic adenocarcinoma of mouse prostate (TRAMP) tissue by 1H-NMR analysis: evidence for unusual phospholipid metabolism.
    Teichert F; Verschoyle RD; Greaves P; Edwards RE; Teahan O; Jones DJ; Wilson ID; Farmer PB; Steward WP; Gant TW; Gescher AJ; Keun HC
    Prostate; 2008 Jul; 68(10):1035-47. PubMed ID: 18459103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Directed expression of Gata2, Mash1, and Foxa2 synergize to induce the serotonergic neuron phenotype during in vitro differentiation of embryonic stem cells.
    Nefzger CM; Haynes JM; Pouton CW
    Stem Cells; 2011 Jun; 29(6):928-39. PubMed ID: 21472823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Achaete-scute homolog-1 and Notch in lung neuroendocrine development and cancer.
    Ball DW
    Cancer Lett; 2004 Feb; 204(2):159-69. PubMed ID: 15013215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.